Product Brochure

Introduction to eLAS®

Format: PDF file | Document type: Product Brochure

Introduction to eLAS®

Related categories: Data management, Phase I-II, Phase III-IV

Clinical Ink has developed a unique offering — the electronic Lupus Assessment Suite (eLAS®​) to address fundamental challenges impacting systemic lupus erythematosus (SLE) studies and the integrity of the study endpoints.
eLAS is a therapeutic-specific application of Clinical Ink’s Lunexis™. Unlike other applications that simply offer stand-alone electronic versions of questionnaires, eLAS features a fully integrated suite of SLE disease assessment questionnaires, physical assessment, tender/swollen joint count, PGA, and summary forms.

Latest content from Clinical Ink

Accelerating Database Lock: Adaptive Design & Remote Monitoring

Content provided by Clinical Ink

Accelerating Database Lock: Adaptive Design & Remote Monitoring

CASE STUDY: A pharmaceutical company conducting a Phase III study of an investigational ointment required an eSource solution that could support remote monitoring, video uploads, and image capture and provide push-button randomization.

Related resources from Clinical Ink

Supplier info centre